Please login to the form below

Not currently logged in
Email:
Password:

US court upholds Crestor patent

The US District Court, District of Delaware, has found that the substance patent protecting Crestor is valid and enforceable

The US District Court, District of Delaware, has found that the substance patent protecting Crestor is valid and enforceable. The ruling, delivered by Judge Joseph Farnan Jr, followed a suit filed by AstraZeneca (AZ) and Shionogi against eight generic drug manufacturers that had challenged the '314 substance patent covering rosuvastatin calcium (the active ingredient in Crestor).

According to Judge Farnan, no inequitable conduct was committed by any employees of Shionogi. The court also held the '314 patent to be non-obvious and properly reissued.

Judge Farnan's subsequent entry of judgement will preclude the US Food and Drug Administrtaion (FDA) from issuing final approvals for the defendants' Abbreviated New Drug Applications (ANDAs) prior to the expiration of the '314 patent in 2016.

David Brennan, CEO, AZ, commented: "We are pleased with the court's decision upholding the validity and enforceability of the '314 substance patent. The court's decision reaffirms the strength of the intellectual property protecting Crestor."

Crestor is AZ's third best-selling drug, achieving sales of $4.5bn in 2009.

30th June 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....